Follicular Flushing During Abdominal Egg Retrieval in Women with Low Egg Reserve
Official title: Follicular Flushing Versus Direct Aspiration in Transabdominal Oocyte Retrieval
Run by Centrum Clinic IVF Center · NCT07877025 · Data updated 2026-11-12
This study tests whether rinsing the egg sacs during abdominal egg collection yields more eggs and more mature eggs for freezing in women with low ovarian reserve.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 42 Years |
| Sex | Women only |
| Enrollment | 180 (estimated) |
| Sponsor | Centrum Clinic IVF Center Academic / other |
| Locations | 2 sites (Ankara, Ankara and 1 other locations) |
| Status | Recruiting |
| Started | August 20, 2026 |
| Main results expected | December 20, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT07877025 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Unmarried women aged 18-42 with AMH ≤1.0 ng/mL who are opting for fertility preservation via transabdominal oocyte retrieval.
✕Probably not a fit
Women not experiencing improved egg yield with flushing or those with ovarian factors limiting retrieval may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational, two-centre study compares two abdominal oocyte retrieval techniques in women who have decided to freeze their eggs and have AMH ≤1.0 ng/mL. Centre A uses direct aspiration only, while Centre B uses systematic follicular flushing with a double-channel needle and multiple rinses if needed. The aim is to see if flushing increases the total number of eggs retrieved and the number of mature eggs suitable for freezing. All procedures are performed by experienced operators under standard stimulation protocols, and enrollment follows Turkish regulatory guidelines for oocyte cryopreservation.
Why it matters
Potential benefit: If flushing proves beneficial, it could improve egg yield and freezing potential for women with diminished ovarian reserve undergoing transabdominal retrieval.
How similar studies have gone: Previous randomized trials in transvaginal IVF have not shown a clear benefit from flushing; this study explores flushing specifically in transabdominal retrieval for poor responders, a relatively underexplored area.
Who can join: the full rules
Show full inclusion / exclusion criteria
IEligibility Criteria Inclusion Criteria: * Women aged 18-42 years * Serum anti-Müllerian hormone (AMH) ≤1.0 ng/mL * Planned oocyte cryopreservation for fertility preservation * Decline of transvaginal oocyte retrieval for cultural or personal reasons, with transabdominal retrieval chosen as the preferred route * Eligible for oocyte cryopreservation under Turkish regulations * At least one follicle ≥17 mm on the day of ovulation trigger * Written informed consent Exclusion Criteria: * Conditions that prevent safe transabdominal access, such as extensive pelvic adhesions or unfavourable ovarian position * Previous major abdominal or pelvic surgery likely to interfere with the procedure * Active pelvic infection * Suspected ovarian malignancy * Contraindications to sedation or oocyte retrieval * Retrieval performed outside local regulatory requirements * Incomplete clinical or laboratory data
Where it's running
-
Centrum Clinic IVF Center
Ankara, Ankara, Turkey (Türkiye) Recruiting -
Brussels IVF Center
Istanbul, Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Emre pabuçcu, Professor
- Email: emregpabuccu@gmail.com
- Phone: 05324147844
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
GnRH agonist versus dual hCG/GnRH trigger for ovulation induction in fertility preservation
We will test whether using a GnRH agonist alone or a dual trigger (GnRH agonist plus hCG) gives better egg retrieval numbers and safety for people with cancer doing egg freezing before gonadotoxic treatment.
-
Combining ovarian tissue freezing with egg (oocyte) freezing versus egg freezing alone
This research will test whether combining ovarian tissue freezing with egg freezing helps adult women with cancer preserve more fertility than egg freezing alone.
-
Long-term follow-up of fertility preservation in women after cancer remission
This project will see how fertility preservation options work long-term for women in remission from cancer or hematological disease, including how often preserved material is used and the psychological effects.
-
When to start hormones after stopping combined birth control for planned egg freezing
This trial tests whether taking a two-month break from combined hormonal birth control versus starting ovarian stimulation immediately affects outcomes for ovary-bearing people aged 18–40 who are planning to freeze their eggs.
-
Fertility-preserving hysteroscopic treatment outcomes for endometrial cancer and atypical hyperplasia
This project tests whether removing lesions by hysteroscopy combined with hormonal therapy helps women with endometrial cancer or atypical hyperplasia preserve fertility and achieve good pregnancy and cancer-control outcomes.
-
Intranasal Nafarelin to Trigger Final Egg M maturation in Fertility Preservation
This trial tests whether intranasal nafarelin can trigger final oocyte maturation as effectively as subcutaneous triptorelin for women freezing oocytes for fertility preservation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.